| PACKAGING TYPE: | 10x10 Tablets In C-box |
| COMPOSITION: | Glibenclamide 5mg + Metformin Hydrochloride 500mg |
| FORMULATION: | Tablets |
| Description: | GLYBMET-M 5/500 Tablets contain Glibenclamide 5 mg and Metformin Hydrochloride 500 mg. This combination is used for the management of Type 2 Diabetes Mellitus when diet, exercise, and single-drug therapy are not sufficient to control blood glucose levels. Glibenclamide is a sulfonylurea that increases insulin secretion from the pancreas, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Together, they provide effective dual control of blood sugar levels. |
| Side Effects: | Hypoglycemia (low blood sugar) Nausea or abdominal discomfort Weight gain (mainly due to sulfonylurea) Metallic taste (Metformin) Diarrhea (Metformin) |
| How to Use: | To be taken orally as prescribed by physician Usually taken with meals to reduce gastric side effects Dosage depends on blood glucose levels Regular monitoring of blood sugar is required |
| Precaution: | Use under strict medical supervision Monitor blood glucose regularly Caution in elderly patients (risk of hypoglycemia) Avoid alcohol (risk of lactic acidosis with Metformin) Not recommended in Type 1 diabetes |
| Product Benefits: | Dual mechanism for better glycemic control Reduces fasting and post-meal blood glucose Improves insulin sensitivity Helps in long-term diabetes management Cost-effective oral anti-diabetic therapy Widely used in Type 2 diabetes |
| Expiry Date: | 2028-02-29 |
Frequently Asked Questions
It is used for Type 2 Diabetes Mellitus control.
Yes, Glibenclamide can cause hypoglycemia if not properly managed.
Yes, usually once or twice daily as prescribed.










